Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet349(9061),1269–1276 (1997).
  Medline CASGoogle Scholar
• 2  Wu Z, Yao C, Zhao D et al.: Sino-monica project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation103(3),462–468 (2001).
  Medline CASGoogle Scholar
• 3  Andre C, Curioni CC, Braga da Cunha C, Veras R: Progressive decline in stroke mortality in brazil from 1980 to 1982, 1990 to 1992, and 2000 to 2002. Stroke37(11),2784–2789 (2006).
  MedlineGoogle Scholar
• 4  Bonita R, Solomon N, Broad JB: Prevalence of stroke and stroke-related disability. Estimates from the auckland stroke studies. Stroke28(10),1898–1902 (1997).
  Medline CASGoogle Scholar
• 5  Cramer SC: Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann. Neurol.63(3),272–287 (2008).
  MedlineGoogle Scholar
• 6  Mendez-Otero R, De Freitas GR, Andre C, De Mendonca ML, Friedrich M, Oliveira-Filho J: Potential roles of bone marrow stem cells in stroke therapy. Regen. Med.2(4),417–423 (2007).
  CASGoogle Scholar
• 7  Kondziolka D, Wechsler L, Goldstein S et al.: Transplantation of cultured human neuronal cells for patients with stroke. Neurology55(4),565–569 (2000).▪▪ First clinical trial of cell therapy for patients with stroke.
  Medline CASGoogle Scholar
• 8  Kondziolka D, Steinberg GK, Wechsler L et al.: Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg.103(1),38–45 (2005).
  MedlineGoogle Scholar
• 9  Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis.20(2),101–107 (2005).
  MedlineGoogle Scholar
• 10  Bang OY, Lee JS, Lee PH, Lee G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol.57(6),874–882 (2005).▪▪ First reported clinical trial using autologous bone marrow mesenchymal cells in ischemic stroke.
  MedlineGoogle Scholar
• 11  Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L et al.: Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor. Neurol. Neurosci.27(3),151–161 (2009).
  MedlineGoogle Scholar
• 12  Pimentel-Coelho PM, Mendez-Otero R: Cell therapy for neonatal hypoxic-ischemic encephalopathy. Stem Cells Dev.19(3),299–310 (2010).
  MedlineGoogle Scholar
• 13  de Vasconcelos dos Santos A, da Costa Reis J, Diaz Paredes B et al.: Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res.1306,149–158 (2010).
  Medline CASGoogle Scholar
• 14  Giraldi-Guimaraes A, Rezende-Lima M, Bruno FP, Mendez-Otero R: Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res.1266,108–120 (2009).
  Medline CASGoogle Scholar
• 15  Pimentel-Coelho PM, Magalhaes ES, Lopes LM, Deazevedo LC, Santiago MF, Mendez-Otero R: Human cord blood transplantation in a neonatal rat model of hypoxic–ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev.19(3),351–358 (2010).
  MedlineGoogle Scholar
• 16  Ribeiro-Resende VT, Pimentel-Coelho PM, Mesentier-Louro LA et al.: Trophic activity derived from bone marrow mononuclear cells increases peripheral nerve regeneration by acting on both neuronal and glial cell populations. Neuroscience159(2),540–549 (2009).
  Medline CASGoogle Scholar
• 17  Zaverucha-Do-Valle C, Gubert F, Bargas-Rega M et al.: Bone-marrow mononuclear cells increase retinal ganglion-cell survival and axon regeneration in the adult rat. Cell Transplant. (2010) (In Press).
  MedlineGoogle Scholar
• 18  Nakano-Doi A, Nakagomi T, Fujikawa M et al.: Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells28(7),1292–1302 (2010).
  Medline CASGoogle Scholar
• 19  Barbosa da Fonseca LM, Battistella V, de Freitas GR et al.: Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation120(6),539–541 (2009).
  MedlineGoogle Scholar
• 20  Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH et al.: Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol.221(1),122–128 (2010).
  MedlineGoogle Scholar
• 21  Palestro CJ, Love C, Bhargava KK: Labeled leukocyte imaging: current status and future directions. Q J Nucl. Med. Mol. Imaging53(1),105–123 (2009).
  Medline CASGoogle Scholar
• 22  Banerjee SR, Maresca KP, Francesconi L, Valliant J, Babich JW, Zubieta J: New directions in the coordination chemistry of ⁹⁹mTc: a reflection on technetium core structures and a strategy for new chelate design. Nucl. Med. Biol.32(1),1–20 (2005).
  Medline CASGoogle Scholar
• 23  Nowak B, Weber C, Schober A et al.: Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells. Eur. J. Nucl. Med. Mol. Imaging34(5),715–721 (2007).
  Medline CASGoogle Scholar
• 24  Gholamrezanezhad A, Mirpour S, Ardekani JM et al.: Cytotoxicity of ¹¹¹In-oxine on mesenchymal stem cells: a time-dependent adverse effect. Nucl. Med. Commun.30(3),210–216 (2009).
  Medline CASGoogle Scholar
• 25  Lunde K, Solheim S, Aakhus S et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12),1199–1209 (2006).
  Medline CASGoogle Scholar
• 26  Penicka M, Lang O, Widimsky P et al.: One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart93(7),837–841 (2007).
  Medline CASGoogle Scholar
• 27  Meyer GP, Wollert KC, Lotz J et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation113(10),1287–1294 (2006).
  MedlineGoogle Scholar
• 28  Huikuri HV, Kervinen K, Niemela M et al.: Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur. Heart J.29(22),2723–2732 (2008).
  MedlineGoogle Scholar
• 29  Tendera M, Wojakowski W, Ruzyllo W et al.: Intracoronary infusion of bone marrow-derived selected CD34⁺CXCR4⁺ cells and nonselected mononuclear cells in patients with acute stemi and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) trial. Eur. Heart J.30(11),1313–1321 (2009).
  MedlineGoogle Scholar
• 30  Strauer BE, Brehm M, Zeus T et al.: Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the iact study. J. Am. Coll. Cardiol.46(9),1651–1658 (2005).
  MedlineGoogle Scholar
• 31  Barbosa da Fonseca LM, Xavier SS, Rosado de Castro PH et al.: Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. Int. J. Cardiol. (2010) (In Press).
  MedlineGoogle Scholar
• 32  Bladin CF, Alexandrov AV, Bellavance A et al.: Seizures after stroke: a prospective multicenter study. Arch. Neurol.57(11),1617–1622 (2000).
  Medline CASGoogle Scholar
• 33  Gupta SR, Naheedy MH, Elias D, Rubino FA: Postinfarction seizures. A clinical study. Stroke19(12),1477–1481 (1988).
  Medline CASGoogle Scholar
• 34  Camilo O, Goldstein LB: Seizures and epilepsy after ischemic stroke. Stroke35(7),1769–1775 (2004).
  MedlineGoogle Scholar
• 35  Lossius MI, Ronning OM, Slapo GD, Mowinckel P, Gjerstad L: Poststroke epilepsy: occurrence and predictors – a long-term prospective controlled study (Akershus Stroke Study). Epilepsia46(8),1246–1251 (2005).
  MedlineGoogle Scholar
• 36  Ryvlin P, Montavont A, Nighoghossian N: Optimizing therapy of seizures in stroke patients. Neurology67(12 Suppl. 4),S3–S9 (2006).
  MedlineGoogle Scholar
• 37  Borlongan CV, Hadman M, Sanberg CD, Sanberg PR: Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke35(10),2385–2389 (2004).
  MedlineGoogle Scholar
• 38  Li Y, Chopp M, Chen J et al.: Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab.20(9),1311–1319 (2000).
  Medline CASGoogle Scholar
• 39  Shyu WC, Lin SZ, Yang HI et al.: Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation110(13),1847–1854 (2004).
  Medline CASGoogle Scholar
• 40  Englund U, Bjorklund A, Wictorin K, Lindvall O, Kokaia M: Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl Acad. Sci. USA99(26),17089–17094 (2002).
  Medline CASGoogle Scholar
• 41  Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol.20(11),1103–1110 (2002).
  Medline CASGoogle Scholar
• 42  Lee JP, Jeyakumar M, Gonzalez R et al.: Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med.13(4),439–447 (2007).
  Medline CASGoogle Scholar
• 43  Fujiwara Y, Tanaka N, Ishida O et al.: Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett.366(3),287–291 (2004).
  Medline CASGoogle Scholar
• 44  Pluchino S, Zanotti L, Rossi B et al.: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature436(7048),266–271 (2005).
  Medline CASGoogle Scholar
• 45  Chu K, Kim M, Park KI et al.: Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res.1016(2),145–153 (2004).
  Medline CASGoogle Scholar
• 46  Pollock K, Stroemer P, Patel S et al.: A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol.199(1),143–155 (2006).
  MedlineGoogle Scholar
• 47  Savitz SI, Dinsmore JH, Wechsler LR, Rosenbaum DM, Caplan LR: Cell therapy for stroke. Neuro. Rx1(4),406–414 (2004).
  MedlineGoogle Scholar
• 48  Caplan AI: Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol.213(2),341–347 (2007).▪ Important review on the potential of mesenchymal stem cells for stem cell therapies.
  Medline CASGoogle Scholar
• 49  Vendrame M, Gemma C, De Mesquita D et al.: Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev.14(5),595–604 (2005).
  Medline CASGoogle Scholar
• 50  Prochazka V, Gumulec J, Jaluvka F et al.: Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant (2010) (In Press).
  Google Scholar
• 51  Lasala GP, Silva JA, Gardner PA, Minguell JJ: Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis. Angiology61(6),551–556 (2010).
  MedlineGoogle Scholar
• 52  Jiang M, He B, Zhang Q et al.: Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin. Biol. Ther.10(5),667–680 (2010).
  Medline CASGoogle Scholar
• 53  de Freitas GR, Mendonca ML, Bezerra DC et al.: Safety and feasibility of intra-arterial autologous bone marrow mononuclear cell transplantation in acute ischemic stroke. Stroke37(2),624–625 (2006).
  Google Scholar
• 54  Friedrich MA, Machado DC, Raupp E et al.: Transplantation of autologous bone marrow mononuclear cells in acute large middle cerebral artery stroke. Int. J. Stroke1,35 (2006).
  Google Scholar
• 55  Mendonca ML, Freitas GR, Silva SA et al.: [Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke]. Arq. Bras Cardiol.86(1),52–55 (2006).
  MedlineGoogle Scholar
• 56  Shen LH, Li Y, Chen J et al.: One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke38(7),2150–2156 (2007).
  MedlineGoogle Scholar
• 57  Shen LH, Li Y, Chen J et al.: Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab.27(1),6–13 (2007).
  MedlineGoogle Scholar
• 58  Yasuhara T, Matsukawa N, Hara K et al.: Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev.18(10),1501–1514 (2009).
  Medline CASGoogle Scholar
• 59  Stem Cell Participants: Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke40(2),510–515 (2009).▪ An important discussion on the current status of cell therapy for stroke with recommendations for future laboratory and clinical investigations.
  MedlineGoogle Scholar
• 101  Safety Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke http://clinicaltrials.gov/ct2/show/NCT00473057
  Google Scholar